Kaken Pharmaceutical Co., Ltd.
KKPCF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $19,435 | $8,025 | $6,817 | $13,885 |
| Dep. & Amort. | $2,554 | $2,753 | $2,568 | $2,486 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $2,987 | -$6,359 | $592 | -$2,041 |
| Other Non-Cash | $4,804 | -$1,842 | -$724 | -$994 |
| Operating Cash Flow | $29,780 | $2,577 | $9,253 | $13,336 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4,138 | -$1,861 | -$2,206 | -$3,257 |
| Net Acquisitions | -$15,378 | $0 | -$207 | -$4,975 |
| Inv. Purchases | -$400 | $0 | -$200 | $433 |
| Inv. Sales/Matur. | $520 | $516 | $5 | $5 |
| Other Inv. Act. | -$254 | -$4,509 | -$19 | -$94 |
| Investing Cash Flow | -$19,650 | -$5,854 | -$2,627 | -$7,888 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $7,764 | $0 | $0 | $0 |
| Stock Repurch. | -$5,935 | $0 | -$1,340 | -$2,414 |
| Dividends Paid | -$7,198 | -$5,657 | -$5,649 | -$5,714 |
| Other Fin. Act. | $0 | -$1 | -$1 | -$1 |
| Financing Cash Flow | -$5,369 | -$5,658 | -$6,990 | -$8,129 |
| Forex Effect | $0 | $0 | -$1 | $1 |
| Net Chg. in Cash | $4,760 | -$8,935 | -$365 | -$2,680 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $65,325 | $74,260 | $74,625 | $77,305 |
| End Cash | $70,085 | $65,325 | $74,260 | $74,625 |
| Free Cash Flow | $25,388 | $410 | $7,047 | $10,079 |